US Patent Issued to National University Corporation Tokai National Higher Education, Sowakai Medical Foundation on Aug. 11 for "Anti-MEFLIN antibody for use in treatment of cancer in subject having cancer, and pharmaceutical composition comprising the antibody" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,717, issued on Aug. 11, was assigned to National University Corporation Tokai National Higher Education (Nagoya, Japan) and Sowakai Medical Foundation (Kurashiki, Japan).

"Anti-MEFLIN antibody for use in treatment of cancer in subject having cancer, and pharmaceutical composition comprising the antibody" was invented by Atsushi Enomoto (Aichi, Japan), Nobutoshi Esaki (Aichi, Japan), Masahide Takahashi (Aichi, Japan), Yuki Miyai (Aichi, Japan), Ryota Ando (Aichi, Japan), Yukihiro Shiraki (Aichi, Japan), Yoshihiro Nishida (Aichi, Japan), Makoto Matsuyama (Okayama, Japan) and Shino Manabe (Okayama, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A...